This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024.
The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21 pediatric vaccines, including those for Dengue, DTaP, Hepatitis A and B, Hib, HPV, MMR, MCV4, Pneumococcal, Rotavirus, Tdap, and Varicella. The vaccines must be FDA-licensed, have a 12-month minimum shelf life, and be delivered within 15 days to CDC depots. This commercial item acquisition will support immunization programs under the Public Health Service Act and OBRA '93. No small business set-asides were used, reflecting Pfizer's status as a large pharmaceutical manufacturer.
Generated 7/16/24, 12:20 PM